Dataset from A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Glimepiride When Used in Combination With Metformin in Subjects With Type 2 Diabetes

The purpose of this study is to determine the efficacy and safety of TAK-875, once daily (QD), plus metformin compared to glimepiride plus metformin in participants with type 2 diabetes mellitus (T2DM). The purpose of this study is to determine the efficacy and safety of TAK-875, once daily (QD), plus metformin compared to glimepiride plus metformin in participants with type 2 diabetes mellitus (T2DM).

本研究旨在评估每日一次（QD）TAK-875联合二甲双胍（metformin）相较于格列美脲（glimepiride）联合二甲双胍，用于2型糖尿病（type 2 diabetes mellitus, T2DM）受试者的疗效与安全性。本研究旨在评估每日一次（QD）TAK-875联合二甲双胍相较于格列美脲联合二甲双胍，用于2型糖尿病受试者的疗效与安全性。